Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D

NCT05369884 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

216

Enrollment

OTHER

Sponsor class

Conditions

Non-erosive Reflux Disease
Diarrhea-Predominant Irritable Bowel Syndrome

Interventions

DRUG: WPQW granule
DRUG: WPQW granule simulant

Sponsor

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]